You may qualify if you have uncontrolled high blood pressure and either already have a Medtronic Astra or Azure pacemaker or are scheduled to get one soon.
Hypertension or high blood pressure is a chronic condition marked by increased blood pressure in the arteries, having a reading of 130/80 mm Hg or higher. Hypertension does not have obvious symptoms but may lead to serious complications if left untreated.
Hightower Clinical is conducting a new research study to evaluate a novel feature in Medtronic dual-chamber pacemakers that may help improve blood pressure control. This feature, called AVIM (atrioventricular interval modulation), is designed to work alongside your current pacemaker settings. The goal is to assess whether this added technology can safely and effectively support better heart function and blood pressure management.
This study is open to individuals who already have a Medtronic Astra or Azure pacemaker or are scheduled to receive one soon. If you are also living with uncontrolled high blood pressure, you may be eligible to participate. The study involves continued use of your usual medications, along with close monitoring and support from our clinical team.
Hypertension
Upcoming
Oklahoma
You may qualify if you have uncontrolled high blood pressure and either already have a Medtronic Astra or Azure pacemaker or are scheduled to get one soon.
The study is testing a new pacemaker feature (AVIM) to see if it can help improve blood pressure control when used alongside standard treatment.
No. You will continue taking your regular blood pressure medications while participating in the study.